Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin

Specific serological tests are mandatory for reliable SARS-CoV-2 seroprevalence studies but assay specificity may vary considerably between populations due to interference of immune responses to other pathogens. Here, we assess the false positive rates obtained with four commercially available IgG ELISAs in serum panels originating from three different African countries. Article summary lineSeveral commercially available SARS-CoV-2 ELISAs show limited specificity when applied to serum panels of African origin